727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors
| Autor: | Jing Hua, Ricard Masia, Simon Turcotte, John Stagg, Jonathan Hill, Matthew Rausch, Devapregasan Moodley, Marisa Peluso, Secil Koseoglu, Gege Tan, Benjamin Lee, Isabelle Cousineau |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2020-SITC2020.0727 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|